Summary
We examined polymorphisms in exons 3 and 4 of microsomal epoxide hydrolase in 101 patients with colon cancer and compared the results with 203 control samples. The frequency of the exon 3 T to C mutation was higher in cancer patients than in controls (odds ratio 3.8; 95% confidence intervals 1.8–8.0). This sequence alteration changes tyrosine residue 113 to histidine and is associated with lower enzyme activity when expressed in vitro. This suggests that putative slow epoxide hydrolase activity may be a risk factor for colon cancer. This appears to be true for both right- and left-sided tumours, but was more apparent for tumours arising distally (odds ratio 4.1; 95% confidence limits 1.9–9.2). By contrast, there was no difference in prevalence of exon 4 A to G transition mutation in cancer vs controls. This mutation changes histidine residue 139 to arginine and produces increased enzyme activity. There was no association between epoxide hydrolase genotype and abnormalities of p53 or Ki- Ras.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Brockmoller, J., Cascorbi, I., Kerb, R. & Roots, I. (1996). Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome p450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915–3925.
Cantlay, A. M., Smith, C. A. D., Wallace, W. A., Yap, P-L, Lamb, D. & Harrison, D. J. (1994). Heterogeneous and polymorphic expression of glutathione S-transferases in human lung. Thorax 49: 1010–1014.
Cantlay, A. M., Lamb, D., Gillooly, M., Norrman, J., Morrison, D., Smith, C. A. D. & Harrison, D. J. (1995). Association between the CYP1A1 gene polymorphism and susceptibility to emphysema and lung cancer. J Clin Mol Pathol 48: M210–214.
Chenevix-Trench, G., Young, J., Coggan, M. & Board, O. (1995). Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis 16: 1655–1657.
Craft, J. A., Bulleid, N. J., Jackson, M. R. & Burchell, B. (1988). Induction of microsomal epoxide hydrolase by nitrosamines in rat liver. Effect on messenger ribonucleic acids. Biochem Pharmacol 37: 297–302.
Cripps, K. J., Purdie, C. A., Carder, P. J., White, S., Komine, K., Bird, C. C. & Wyllie, A. H. (1994). A study of the stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene 9: 2739–2743.
Giovannucci, E. & Willett, W. C. (1994). Dietary factors and risk of colon cancer. Ann Med 26: 443–452.
Hassett, C., Aicher, L., Sidhu, L. A. & Omiecinski, C. J. (1994). Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421–428.
Hassett, C., Lin, J., Carty, C. L., Laurenzana, E. M. & Omiecinski, C. J. (1997). Human hepatic microsomal epoxide hydrolase: comparative analysis of polymorphic expression. Arch Biochem Biophys 337: 275–283.
Hubbard, A. L., Harrison, D. J., Moyes, C., Wyllie, A. H., Cunningham, C., Mannion, E. & Smith, C. A. D. (1997). N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut 41: 229–234.
Illett, K. F., Ingram, D. M., Carpenter, D. S., Teitel, C. H., Lang, N. P., Kadlubar, F. F. & Minchin, R. F. (1994). Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 47: 914–917.
Kotsinas, A., Spandidos, D. A., Romanowski, P. & Wyllie, A. H. (1993). Relative expression of wild-type and activated Ki-ras2 oncogene in colorectal carcinomas. Int J Oncol 3: 841–845.
Lancaster, J. M., Brownlee, H. A., Bell, D. A., Futreal, P. A., Marks, J. R., Berchuck, A., Wiseman, R. W. & Taylor, J. A. (1996). Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17: 160–162.
Lang, N. P., Chu, D. Z. J., Hunter, C. F., Kendall, D. C., Flammang, T. J. & Kadlubar, F. F. (1986). Role of aromatic amine N-acetyltransferase in human colorectal carcinoma. Arch Surg 121: 1259–1261.
Omiecinski, C. J., Aicher, L., Holubkov, R. & Checkoway, H. (1993). Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150–158.
Probst-Hensch, N. M., Haile, R. W., Ingles, S. A., Longnecker, M. P., Han, C., Lin, B. K., Lee, D. B., Sakamoto, G. T., Frankl, H. D., Lee, E. R. & Lin, H. J. (1995). Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res 55: 2017–2020.
Smith, C. A. D. & Harrison, D. J. (1997). Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350: 630–633.
Strange, R. C., Matharoo, B., Faulder, G. C., Jones, P., Cotton, W., Elder, J. B. & Deakin, M. (1991). The human glutathione S-transferases: a case control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12: 23–28.
Tomlinson, I., Ilyas, M. & Novelli, M. (1997). Molecular genetics of colon cancer. Cancer Metastasis Rev 16: 67–79.
Wohlleb, J. C., Hunter, C. F., Blass, B., Kadlubar, F. F., Chu, D. Z. Z. J. & Lang, N. P. (1990). Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. Int J Cancer 46: 22–30.
Yang, S. K. (1988). Sterioselectivity of cytochrome p-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem Pharmacol 37: 61–70.
Yang, E. K., Radominska, A., Winder, B. S. & Dannenberg, A. J. (1993). Dietary lipids coinduce xenobiotic metabolising enzymes in rat liver. Biochim Biophys Acta 1168: 52–58.
Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R. & Spurr, N. K. (1993). Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821–1824.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Harrison, D., Hubbard, A., MacMillan, J. et al. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 79, 168–171 (1999). https://doi.org/10.1038/sj.bjc.6690028
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690028
Keywords
This article is cited by
-
Genetic enhancement of microsomal epoxide hydrolase improves metabolic detoxification but impairs cerebral blood flow regulation
Archives of Toxicology (2016)
-
Impact of Epoxide Hydrolase 1 Polymorphisms on Lung Cancer Susceptibility in Asian Populations
Cell Biochemistry and Biophysics (2015)
-
Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects
Journal of Experimental & Clinical Cancer Research (2014)
-
Association of microsomal epoxide hydrolase exon 3 Tyr113His and exon 4 His139Arg polymorphisms with gastric cancer in India
Indian Journal of Gastroenterology (2013)
-
Study of the association between glutathione S-transferase (GSTM1, GSTT1, GSTP1) polymorphisms with type II diabetes mellitus in southern of Iran
Molecular Biology Reports (2012)